|
|
SMFM Statement: Response to EPPPIC and considerations of the use of progestogens for the preventi...
|
SMFM Statement
|
SMFM |
2021 |
|
|
SMFM Special Statement: Grading of Recommendations Assessment, Development, and Evaluation (GRADE...
|
SMFM Statement
|
SMFM, M Norton, J Kuller, T Metz |
2021 |
|
|
SMFM Special Statement: Checklist for initial management of amniotic fluid embolism
|
SMFM Statement
|
SMFM, CA Combs, DM Montgomery, LE Toner, GA Dildy |
2021 |
|
|
SMFM Clinical Practice Guidelines Development Process
|
SMFM Statement
|
SMFM |
2020 |
|
|
SMFM Special Statement: Updated checklists for management of monochorionic twin pregnancy
|
SMFM Statement
|
SMFM, I Hoskins, CA Combs |
2020 |
|
|
SMFM Special Statement: A maternal transport briefing form and checklist
|
SMFM Statement
|
SMFM, K Gibson, D McLean |
2020 |
|
|
SMFM Special Statement: Updated checklists for pregnancy management in persons with HIV
|
SMFM Statement
|
SMFM, K Gibson, L Toner |
2020 |
|
|
SMFM Special Statement: Updated checklist for antepartum care of pregestational diabetes mellitus
|
SMFM Statement
|
SMFM, A Hameed, CA Combs |
2020 |
|
|
SMFM Special Statement: Checklist for thromboembolism prophylaxis after cesarean delivery
|
SMFM Statement
|
SMFM, CA Combs |
2020 |
|
|
SMFM Special Statement: Checklist for postpartum discharge of women with hypertensive disorders
|
SMFM Statement
|
SMFM, K Gibson, A Hameed |
2020 |
|
|
SMFM Special Statement: Reducing the risk of transmitting infection by transvaginal ultrasound ex...
|
SMFM Statement
|
SMFM, R Hamm, CA Combs, C Davidson |
2020 |
|
|
SMFM Special Statement: Checklists for preeclampsia risk-factor screening to guide recommendation...
|
SMFM Statement
|
SMFM, CA Combs, D Montgomery |
2020 |
|
|
SMFM Special Statement: Who’s who in patient safety and quality for maternal healthcare in the Un...
|
SMFM Statement
|
SMFM |
2020 |
|
|
SMFM Special statement: Proposed quality metrics to assess accuracy of prenatal detection of cong...
|
SMFM Statement
|
SMFM |
2020 |
|
|
SMFM Special Statement: Operative vaginal delivery: checklists for performance and documentation
|
SMFM Statement
|
SMFM Patient Safety and Quality Committee, B Staat, CA Combs |
2020 |
|
|
SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm ...
|
SMFM Statement
|
SMFM Publications Committee |
2019 |
|
|
SMFM Statement: Elective induction of labor in low-risk nulliparous women at term: The ARRIVE trial
|
OB-GYN, Sub-specialist, Certified Nurse Midwife and Laborist
SMFM Statement
Labor and Delivery
|
SMFM Publications Committee |
2018 |
|
|
SMFM Statement Pharmacological treatment of gestational diabetes
|
OB-GYN, Sub-specialist, Certified Nurse Midwife and Laborist
SMFM Statement
Maternal Medical Complications
|
SMFM Pubs Committee |
2018 |
|
|
The development and implementation of checklists in obstetrics
|
SMFM Statement
Administrative
|
SMFM, P Bernstein, CA Combs, L Shields, S Clark, C Eppes, SMFM Patient Safety and Quality Committee |
2017 |
|
|
SMFM Statement: The role of cervical pessary placement to prevent preterm birth in clinical practice
|
OB-GYN, Sub-specialist, Certified Nurse Midwife and Laborist
SMFM Statement
Obstetric Complications
|
SMFM Publications Committee |
2017 |
